top of page
pexels-jopwell-2422293.jpg

ree

Saul Blecker, MD, MHS is an Associate Professor of Population Health and Medicine at NYU Grossman School of Medicine. He is a general internal medicine physician and researcher focused on improving the quality of care and outcomes for patients with chronic disease. In his research, Dr. Blecker uses electronic health record (EHR) and other large clinical datasets to understand gaps in evidence-based care delivery. He utilizes findings from this data-driven work to guide the development and implementation of electronic tools to improve patient care. Additionally, he uses a combination of advanced analytics, implementation science and practice redesign to address patient adherence to evidence-based therapies.


“Medication Adherence in Hypertension: A Cluster Randomized Clinical Trial”

Presentation by and discussion with first author Saul Blecker, MD, MHS

Thursday, September 25, 2025, 12:00 – 1:00PM ET



Sep 18, 2025 11:00 AM MST

The ASU Roybal Center funds NIH Stage 0–IV behavioral trials focused on developing and testing technology-enabled lifestyle interventions for older adults living alone with cognitive decline. Funded trials apply a mechanism of behavior change (MoBC) approach to identify and test the specific processes or pathways through which interventions are expected influence behavior. This webinar will provide an overview of the Center’s funding priorities and offer guidance on preparing proposals and designing trials that align with the Center’s mission and scope.



Aug 26, 2025 10:00 AM MST

Join the ASU Roybal Center webinar led by Fang Yu, Director of the Center, as she explains the Center’s scientific foci on supporting older adults living alone with cognitive decline through Mechanisms of Behavior Change (MoBC) and technology-enabled behavioral interventions within the context of the NIH Stage Model and Health Disparities Framework. This session will be particularly informative to investigators who are considering to submit a Letter of Intent for the Center’s Call for Trials.



bottom of page